A Pilot Trial of Pox Vector PSA Vaccine With Concurrent Docetaxel Versus Pox Vector Vaccine Followed by Docetaxel in Metastatic Androgen Independent Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 18 Jun 2013
At a glance
- Drugs Rilimogene galvacirepvec (Primary) ; Rilimogene glafolivec (Primary) ; Docetaxel
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 Jun 2013 Last checked against ClinicalTrials.gov record.
- 20 Oct 2008 'National Cancer Institute - Center for Cancer Research-Medical Oncology' added as trial sponsor as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History